TY - JOUR
T1 - Exposure to attention deficit hyperactivity disorder medications during pregnancy
AU - Humphreys, Caitlin
AU - Garcia-Bournissen, Facundo
AU - Ito, Shinya
AU - Koren, Gideon
PY - 2007/7
Y1 - 2007/7
N2 - QUESTION: An 18-year-old patient of mine, currently under treatment for attention deficit hyperactivity disorder (ADHD) with methylphenidate, just found out that she is pregnant. What are the risks for the baby when the mother uses ADHD medications during pregnancy? ANSWER: Available evidence for amphetamines suggests no increased risk of malformations with use of therapeutic doses, and inadvertent exposure during pregnancy is unlikely to be harmful. Human data for methylphenidate and atomoxetine treatment in pregnancy are very limited. Documented cases do not suggest teratogenicity, but we cannot rule out this risk with the information available.
AB - QUESTION: An 18-year-old patient of mine, currently under treatment for attention deficit hyperactivity disorder (ADHD) with methylphenidate, just found out that she is pregnant. What are the risks for the baby when the mother uses ADHD medications during pregnancy? ANSWER: Available evidence for amphetamines suggests no increased risk of malformations with use of therapeutic doses, and inadvertent exposure during pregnancy is unlikely to be harmful. Human data for methylphenidate and atomoxetine treatment in pregnancy are very limited. Documented cases do not suggest teratogenicity, but we cannot rule out this risk with the information available.
UR - http://www.scopus.com/inward/record.url?scp=34547774221&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.shortsurvey???
C2 - 17872810
AN - SCOPUS:34547774221
SN - 0008-350X
VL - 53
SP - 1153
EP - 1155
JO - Canadian Family Physician
JF - Canadian Family Physician
IS - 7
ER -